IFNA1 and type 1 diabetes mellitus: The research indicated that this early IFN transcriptional signature, characterized by the upregulation of numerous genes linked to innate immune responses, could serve as a potential biomarker for predicting disease onset, providing valuable insights into the timing and mechanisms of immune system activation in T1D [40].